Evidera
Ariel Berger has extensive experience in the field of healthcare and public health, currently serving as Executive Director of Integrated Solutions, Real-World Evidence at Evidera since April 2014. Prior to this role, Ariel held positions as US Director of Real World Evidence and Research Scientist at the same company. Previous experience includes serving as a Senior Consultant at MINERVA Health Economics Network and Policy Analysis Inc. Ariel also worked as an Epidemiologist at Medical Scientists, Inc. Educational qualifications include a Master's degree in Public Health with a focus on Epidemiology and Biostatistics from Boston University School of Public Health, as well as a Bachelor of Arts in Political Science from Syracuse University.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.